Supreme Court Halts NIH's Grant Distribution

In a narrow 5-4 decision on Thursday, the Supreme Court has provisionally permitted the National Institutes of Health to halt disbursement of around $783 million earmarked for research grants. This comes amidst a shift in administrative strategies.

The recent ruling also maintains, for the time being, a lower court's decision that invalidated specific NIH memos connected to the administration's policy enforcement.

Justice Amy Coney Barrett joined her conservative peers on this decision, with the exception of Chief Justice John Roberts, who joined the court's liberal justices.

Earlier this year, the NIH began withdrawing federally funded grants from numerous projects not aligning with the Trump administration's directives—particularly those examining diversity, equity, and inclusion (DEI) or gender identity-related research.

The agency's actions, described as an 'ideological cleanse' by some, including Robert F. Kennedy Jr., also saw the cessation of funding for studies on vaccine resistance and COVID-19's societal impact, which the NIH claims have exceeded their original scope.

Controversy and Legal Actions

The NIH maintains that grant awards can be retracted if they deviate from the agency's strategic goals, referencing a precedent set by an earlier Supreme Court case that permitted withholding DEI-linked funding from the Department of Education during ongoing litigation.

However, opposition emerged from sixteen states, along with various advocacy groups and researchers, charging the NIH and Kennedy with acting unconstitutionally by terminating these grants.

A federal judge initially restored these grants temporarily, criticizing the NIH for disrupting what he perceived as the agency's long-standing neutrality. Nonetheless, this decision was effectively stalled by the Supreme Court's latest intervention, aligning with previous judgments to suspend expenditures while awaiting further judicial review.